Biotech Values

[DewDiligence]

More lack of fact-checking at TMF:

http://beta.fool.com/adamlevy/2012/11/12/new-developments-abbott-labs/16199

Abbott Labs will grow faster without its mature pharma segment. Of course, this comes with a lower dividend yield. On the other hand, AbbVie will pay a nice juicy dividend to income investors, but growth will come more slowly. The exact amounts of the dividend for each company are unknown, but they should add up to Abbott’s current $2.04 annual dividend.

Wrong! ABT disclosed the new dividend payouts last month on the 3Q12 CC; as noted in #msg-80866249, the payouts sum to $2.12 ($1.60 for ABBV, and $0.56 for "new" ABT).